Markers of neutrophil mediated inflammation associate with disturbed continuous electroencephalogram after out of hospital cardiac arrest.

"CONFLICT OF INTEREST Giuseppe Ristagno has served at data monitoring committee for DSMB trial: TRansfusion Strategies in Acute Brain INjured Patients (TRAIN). Kaj Blennow has received consulting fees from Abcam, Axon, BioArctic, Biogen, JOMDD/Shimadzu, Lilly, MagQu, Prothena, Roche Diagnostics and Siemens Healthineers; honoraria for lectures from: GEECD/Roche Diagnostics and IFCC/SNIBE; has served at data monitoring committees for: Julius Clinical and Novartis and he is a co‐founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. Henrik Zetterberg has served at scientific advisory boards and/or as a consultant for Abbvie, Alector, Annexon, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Pinteon Therapeutics, Red Abbey Labs, Passage Bio, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co‐founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. Jussi Toppila has received consulting/lecture fees from: UCB Pharma Finland and SGS Fimko Ltd."

"Funding information Einar och Karin Stroems stiftelse; Finska Läkaresällskapet; Helsinki University Hospital, Grant/Award Number: M7100YLIT2"